Randomized follow-up study of resected NSCLC patients: Conventional versus 18F-DG coincidence imaging

Anticancer Research

Volumn 30, Issue 9, 2010, Pages 3811-3816

  Monteil, J ^a   Vergnenegre A ^a   Bertin, F ^a   Dalmay, F ^a   Gaillard, S ^a   Bonnaud, F ^a   Melloni, B ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Early detection; FDG imaging; Follow up; Lung cancer; Recurrence; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; ERLOTINIB; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADRENAL CANCER; ADULT; AGED; ARTICLE; BONE CANCER; BONE SCINTISCANNING; BRAIN CANCER; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; COINCIDENCE DETECTION EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; ECHOGRAPHY; EMISSION TOMOGRAPHY; FEMALE; FOLLOW UP; HEAD AND NECK TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER CANCER; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC USE; GAMMA CAMERA; LUNG TUMOR; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROCEDURES; SCINTISCANNING; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GAMMA CAMERAS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 77958541464     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW and Ginsberg RJ: Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109(1): 120-129, 1995.
2. Korst RJ, Kansler AL, Port JL, Lee PC and Altorki NK: Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer. Ann Thorac Surg 82(3): 1009-1105, 2006.
3. 18F-fluorodeoxyglucose positron Imaging using coincidence mode gamma cameras. J Nucl Med 40(4): 574-578, 1999. (Pubitemid 29171798)
4. 18F- fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases. Eur Respir J 24(5): 814-821, 2004. (Pubitemid 39504437)
5. Tambour M and Zethraeus N: Bootstrap confidence intervals for cost-effectiveness ratios: some simulation results. Health Econ 7(2): 143-147, 1998.
6. Egermann U, Jaeggi K, Habicht JM, Perruchoud AP, Dalquen P and Solèr M. Regular follow-up after curative resection of non-small cell lung cancer: a real benefit for patients? Eur Respir J 19(3): 464-468, 2002.
7. Edelman MJ and Schuetz J: Follow-up of local (stage I and stage II) non-small cell lung cancer after surgical resection. Curr Treat Options Oncol 3(1): 67-73, 2002.
8. ESMO Guidelines Working Group and Besse B. Non-small cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 18(Suppl 2): ii30-31, 2007.
9. nd edition). Chest 132(3 Suppl): 355S-367S, 2007.
10. Saunders M, Sculier JP, Ball D, Capello M, Furuse K, Goldstraw P, Meert AP, Ninane V, Ohe Y, Paesmans M, Park K, Pirker R, Postmus P and Sokolow Y: Consensus: the follow-up of the treated patient. Lung Cancer 42 Suppl 1:S17-19, 2003.
11. Colice GL, Rubins J and Unger M; American College of Chest Physicians. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest 123(1 Suppl): 272S-283S, 2003.
12. Westeel V, Choma D, Clément F, Woronoff-Lemsi MC, Pugin JF, Dubiez A and Depierre A: Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg 70(4): 1185-1190, 2000.
13. Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps C, Williams BA and Pairolero PC: Survival after recurrent non-small cell lung cancer after complete pulmonary resection. Ann Thorac Surg 83(2): 409-417, 2007.
14. Bury T, Corhay JL, Duysinx B, Daenen F, Ghaye B, Barthelemy N, Rigo P and Bartsch P: Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J 14(6): 1376-1380, 1999. (Pubitemid 30019536)
15. Tatsumi M, Yutani K, Watanabe Y, Miyoshi S, Tomiyama N, Johkoh T, Kusuoka H, Nakamura H and Nishimura T: Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET. J Nucl Med 40(4): 566-573, 1999. (Pubitemid 29171797)
16. Zhang H, Tian M, Oriuchi N, Higuchi T, Tanada S and Endo K: Detection of lung cancer with positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET. Eur J Radiol 47(3): 199-205, 2003.
17. 18FDG-CDET in the evaluation of opérable bronchial cancer. Rev Mal Respir 18(6 Pt 1): 599-606, 2001.
18. 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. Nucl Med 45(10): 1640-1646, 2004.
19. Hellwig D, Gröschel A, Graeter TP, Hellwig AP, Nestle U, Schäfers HJ, Sybrecht GW and Kirsch CM: Diagnostic performance and prognostic impact FDG-PET in suspected récurrence of surgically treated non-small cell lung cancer. Eur J Nucl Med Mol Imaging 33(1): 13-21, 2006.
20. Hicks RJ, Kalff V, MacManus MP, Ware RE, McKenzie AF, Matthews JP and Ball DL: The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification. Nucl Med 42(11): 1605-1613, 2001. (Pubitemid 33131318)
21. Takenaka D, Ohno Y, Koyama H, Nogami M, Onishi Y, Matsumoto K, Matsumoto S, Yoshikawa T and Sugimura K: Integrated FDG-PET/CT vs. standard radiological examinations: Comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients. Eur J Radiol (http://dx.doi.org/10.1016/j.ejrad.2009.03.007), 2009.
22. Kent MS, Korn P, Port JL, Lee PC, Altorki NK and Korst RJ: Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model. Ann Thorac Surg 80(4): 1215-1222, 2005.
23. 18F]-2-fluoro-deoxy-D-glucose-positron- emission tomography scan in potentially resectable non-small cell lung cancer. Chest 125(4): 1413-1423, 2004.
24. Alzahouri K, Lejeune C, Woronoff-Lemsi MC, Arveux P and Guillemin F: Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small cell lung cancer from the French healthcare system perspective. Clin Radiol 60(4): 479-492, 2005.
25. nd: Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence. J Thorac Oncol 2(6): 499-505, 2007.